Project Grant R01NS129984
Award Date
8/20/24
Completion Date
6/30/29
Dollars Obligated
$1.6M
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to investigate how temporal lobe seizures with different onset patterns propagate through the basal ganglia and evaluate the implications of this circuit in controlling temporal lobe seizures. The $674,409.00 award, granted on Sep 11, 2024, will support a...
This federal Project Grant award of $657,958, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to elucidate the cellular and network mechanisms underlying epileptic activity and seizures, as well as investigate the neuronal impact of neurostimulation for treating drug-resistant epilepsy. The 5-year award to Trustees of Boston University...
This federal Project Grant award, ID R01NS137650, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $580,070 award, effective December 1, 2024 through November 30, 2029, will support research at Stanford University to study the role of the human thalamus in the propagation of temporal lobe seizures and memory formation. The key products and...
The federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research aimed at developing a highly personalized approach to thalamic neuromodulation for treating drug-resistant epilepsy. The $256,500 award, spanning from January 1, 2025 to December 31, 2029, will enable the principal investigator at Mayo Clinic to: 1) map...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $690,763 to Brigham & Women's Hospital Inc. to research optimizing neuromodulation therapies for epilepsy. The project aims to identify factors that determine patient response to responsive neurostimulation (RNS), focusing on connectivity, stimulation timing, and background...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $438,836 to The Trustees of the Stevens Institute of Technology under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research to develop a unified paradigm using simultaneous multimodal measurement of scalp EEG and intracranial EEG (iEEG) signals to estimate the electrophysiological networks of the whole brain....
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $469,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Michigan Technological University. The grant, titled "Dissecting Neural Circuit Mechanisms Underlying Pallidal Deep Brain Stimulation," will fund research to identify the neural elements and circuits necessary for the therapeutic effects of deep brain stimulation (DBS) of the globus...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $231,325 to support research on the neurophysiological signatures of essential tremor and the effects of deep brain stimulation (DBS) on these neural dynamics. The primary awardee, The Trustees of the University of Pennsylvania, will use multimodal neurophysiology techniques,...
This $1,365,844 Cooperative Agreement award, granted by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports a Phase 2 clinical trial to determine the cognitive and motor effects of theta burst deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease patients. The award aims to evaluate whether short-term and chronic theta burst STN...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $465,500.00 to Trustees of Boston University to conduct research on "Close-Loop Deep Brain Optoacoustic Stimulation at Sub-Millimeter Precision". The award has a start date of July 5, 2025 and an ultimate completion date of June 30, 2027. The research aims to...